Amentum (AMTM) Q2 2026 Earnings Transcript

Amentum reported Q2 revenue of $3.5 billion, adjusted EBITDA of $275 million, and adjusted EPS of $0.60, while backlog reached a record nearly $48 billion and net bookings were $4 billion, implying a 1.2x book-to-bill. Management reaffirmed FY26 guidance for revenue of $13.95 billion-$14.3 billion, EBITDA of $1.1 billion-$1.14 billion, EPS of $2.25-$2.45, and free cash flow of $525 million-$575 million. Post-quarter refinancing lowered the weighted average cost of debt by about 50 bps and left the company on track to reach net leverage below 3x by year-end.

Analysis

AMTM is de-risking the story in the one way the market cares about most for services platforms: backlog quality is improving faster than revenue growth. The mix shift toward funded backlog and new-business awards suggests less dependence on near-term recompetes, which should compress the probability of a growth air pocket in FY27 even before the reported pipeline converts. The refinancing matters more than the headline EBITDA beat because it lowers the equity risk premium: every 50 bps of debt cost relief expands optionality into buybacks, tuck-in M&A, or further debt paydown once leverage gets into the high-2x zone.

The second-order winner is anyone exposed to Amentum’s enablement layer in AI infrastructure and nuclear buildout. If CDI and SMR activity keeps moving from “design/policy” to “execution,” suppliers of power, cooling, network gear, and specialty engineering will see follow-on demand with better pricing power than the primes that merely assemble the work. The risk is that management’s confidence in FY27 is doing some heavy lifting ahead of actual awards; a modest revenue hit from NASA alone is manageable, but if federal procurement slips or data-center conversion cycles elongate, the 10%+ FCF growth path becomes more back-half weighted than the market expects.

This is still not an obvious short: the market may be underestimating how much of the backlog is now tied to structurally expanding end markets rather than cyclical government timing. But the multiple can only expand if investors believe margins can hold while growth accelerates, and that requires evidence that new-start ramp friction is temporary rather than endemic. The most important catalyst over the next 1-2 quarters is award conversion in CDI and nuclear; if those programs stack up, AMTM can re-rate as a cash-generative infrastructure-defense compounder instead of a post-merger integration story.

Key Decisions for Investors

• Long AMTM on a 3-6 month horizon into FY27 award conversions; use pullbacks near post-earnings consolidation for entry. Upside case is multiple expansion as leverage falls below 3x and backlog converts into higher-quality growth.
• Buy AMTM Jan-2027 calls or call spreads to express the view that FY27 revenue drag from NASA is more than offset by CDI and nuclear awards. Risk is award timing slippage; options cap downside while preserving upside convexity.
• Pair trade: long AMTM / short a slower-growth government services peer with weaker backlog quality over the next 2 quarters. The relative long should benefit if the market starts rewarding book-to-bill and funded backlog more than reported revenue.
• Watch for a better entry into data-center infrastructure names exposed to retrofit and power/cooling spend over the next 6-12 months. AMTM’s commentary implies follow-on work; contractors and electrical infrastructure suppliers may be the cleaner expression of the AI capex theme.
• If AMTM rallies sharply before award conversion evidence, trim into strength and rotate part of the exposure into industrials/capex beneficiaries with less contract-timing risk. The main failure mode is enthusiasm outrunning actual procurement cadence.